Tag: medical device clinical trials market growth

Uncover key drivers, emerging technologies, and competitive movements shaping the medical device clinical trials market from 2025–2034 with trusted insights from The Business Research Company

What Is The Present Size Of The Medical Device Clinical Trials Market And What Value Is Projected For 2029?

The medical device clinical trials market size has demonstrated substantial growth in recent years. This market is expected to expand from $16.87 billion in 2024 to $18.07 billion in 2025, achieving a compound annual growth rate (CAGR) of 7.1%. The expansion observed in the historical period stems from various factors, including the increasing prevalence of chronic diseases, a rising demand for innovative medical technologies, regulatory support for clinical research, an expanding aging population, improvements in healthcare infrastructure, and heightened investment from both public and private sectors.

The medical device clinical trials market is projected for substantial expansion over the upcoming years. Its value is anticipated to reach $23.75 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 7.1%. This growth during the forecast period is fueled by factors such as a heightened demand for personalized medical devices, an increased emphasis on real-world evidence, the expanding application of artificial intelligence in trial design and oversight, the proliferation of decentralized and virtual trials, regulatory frameworks facilitating quicker approvals, and a surge in investments aimed at digital health innovations. Key trends foreseen in the same period involve the embrace of decentralized trials, the incorporation of AI and big data analytics, the deployment of wearable monitoring devices, improved regulatory harmonization, and continuous progress in trial design and data analytics.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24295&type=smp

What Factors Are Boosting The Medical Device Clinical Trials Market?

The increasing occurrence of chronic illnesses is anticipated to fuel the expansion of the medical device clinical trials market in the future. These are health conditions that persist over time, develop gradually, and necessitate continuous medical care. Their rise is attributed to inactive lifestyles, where extended periods of sitting or device usage decrease calorie burning and impair cardiovascular well-being, resulting in conditions like obesity, diabetes, and high blood pressure. This surge in chronic diseases creates a demand for medical device clinical trials to create and confirm novel devices for accurate diagnosis, effective treatment, and proper management. An example of this is the report from June 2023 by the Institute for Health Metrics and Evaluation, a US-based public health research institute, stating that over half a billion individuals worldwide had diabetes. This figure is projected to more than double, reaching 1.3 billion people by 2050. Consequently, the escalating occurrence of chronic illnesses is stimulating the growth of the medical device clinical trials market.

What Are The Core Segmentation Criteria In The Medical Device Clinical Trials Market?

The medical device clinical trials market covered in this report is segmented –

1) By Study Type: Feasibility And Pilot Study, Pivotal Study, FDA Premarket Approval (PMA) Application, Post-Approval Study

2) By Indication: Cardiovascular Devices, Neurology Devices, Orthopedic Devices, Diagnostic Imaging, Anesthesia And Respiratory Devices, Other Indications

3) By Study Design: Interventional, Observational, Expanded Access

Subsegments:

1) By Feasibility And Pilot Study: First-in-Human (FIH) Trials, Device Safety Assessment, Procedural Feasibility Studies, Prototype Testing

2) By Pivotal Study: Comparative Effectiveness Studies, Randomized Controlled Trials (RCTs), Non-Inferiority Trials, Superiority Trials

3) By FDA PMA (Pre-Market Approval) Application: Clinical Data Submission, Device Risk Analysis, Effectiveness Evidence Studies, Manufacturing Process Validation

4) By Post-Approval Study: Long-Term Safety Monitoring, Real-World Evidence Collection, Registry Studies, Comparative Outcome Studies

Which Emerging Trends Are Reshaping The Medical Device Clinical Trials Market Landscape?

Major companies engaged in the medical device clinical trials market are concentrating on creating AI-powered medical device software. This endeavor seeks to optimize clinical trial protocols and resource distribution, thereby enhancing trial efficiency and reducing costs. AI-powered medical device software pertains to healthcare applications that harness artificial intelligence (AI) algorithms, especially machine learning or deep learning, to aid or automate medical tasks. For example, in January 2025, Risklick, a pharmaceutical company based in Switzerland, launched Protocol AI. This AI-based software is specifically designed to accelerate and optimize clinical trials for medical devices. Protocol AI utilizes Natural Language Processing (NLP) and Machine Learning (ML) to analyze clinical data, publications, and regulatory documents, automatically generating clinical trial protocols in mere minutes. This innovation considerably decreases the time and expenditure required for protocol development, a process that traditionally takes around six months, and has already shown up to a 50% reduction in document development time for medicinal products.

Which Players Are Shaping The Competitive Landscape Of The Medical Device Clinical TrialsXX Market?

Major companies operating in the medical device clinical trials market are Abbott Laboratories, Siemens Healthineers, Stryker Corporation, Philips Healthcare, Baxter International, Roche Diagnostics, ICON, Intuitive Surgical, Edwards Lifesciences, Fortrea, Medidata, NAMSA, Veranex, TFS HealthScience, Avania, Parexel, Meditrial, Syneos Health, Qserve CRO, Clinius Ltd, Eclevar Medtech, 1med Sa, ISS AG

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/medical-device-clinical-trials-global-market-report

What Regional Trends Are Shaping Growth In The Medical Device Clinical Trials Market?

North America was the largest region in the medical device clinical trials market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medical device clinical trials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=24295&type=smp

Browse Through More Reports Similar to the Global Medical Device Clinical Trials Market 2025, By The Business Research Company

Medical Refrigerators Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/medical-refrigerators-global-market-report

Medical Plastics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/medical-plastics-global-market-report

Medical Adhesive Tapes Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/medical-adhesive-tapes-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Is The Projected Market Size Of The Medical Device Clinical Trials Market By 2029?

The medical device clinical trials market has experienced substantial growth in recent years. This market is projected to expand from $16.87 billion in 2024 to $18.07 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 7.1%. The historical growth can be attributed to factors such as the rising incidence of chronic diseases, increasing demand for innovative medical technologies, supportive regulatory frameworks for clinical research, a growing aging population, the expansion of healthcare infrastructure, and increased investment from both public and private sectors.

The medical device clinical trials market is anticipated to experience robust expansion in the coming years. It is projected to increase to $23.75 billion by 2029, showing a compound annual growth rate (CAGR) of 7.1%. This growth during the forecast period is driven by factors such as the rising demand for personalized medical devices, an increased focus on real-world evidence, the growing integration of AI in trial design and monitoring, the expansion of decentralized and virtual trials, regulatory frameworks that support quicker approvals, and escalating investments in digital health innovations. Key trends identified for the forecast period include the broader adoption of decentralized trials, the integration of AI and big data analytics, the utilization of wearable monitoring devices, enhanced regulatory harmonization efforts, and advancements in trial design and data analytics.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24295&type=smp

Which Drivers Are Impacting The Medical Device Clinical Trials Market?

The increasing occurrence of chronic diseases is anticipated to propel the growth of the medical device clinical trials market going forward. These conditions are defined as persistent health issues that develop gradually and necessitate continuous medical attention. The rise in chronic diseases can be attributed to sedentary lifestyles, involving prolonged periods of sitting at desks or using electronic devices. Such habits decrease calorie burning and impair cardiovascular health, resulting in conditions like obesity, diabetes, and hypertension. This surge in chronic ailments necessitates medical device clinical trials to innovate and verify devices for their effective diagnosis, treatment, and management. As an illustration, in June 2023, the Institute for Health Metrics and Evaluation, a US-based public health research institute, disclosed that more than half a billion individuals worldwide suffered from diabetes. This figure is projected to more than double, reaching 1.3 billion people by 2050. Consequently, the increasing incidence of chronic diseases is fueling the expansion of the medical device clinical trials market.

How Is The Medical Device Clinical Trials Market Segmented?

The medical device clinical trials market covered in this report is segmented –

1) By Study Type: Feasibility And Pilot Study, Pivotal Study, FDA Premarket Approval (PMA) Application, Post-Approval Study

2) By Indication: Cardiovascular Devices, Neurology Devices, Orthopedic Devices, Diagnostic Imaging, Anesthesia And Respiratory Devices, Other Indications

3) By Study Design: Interventional, Observational, Expanded Access

Subsegments:

1) By Feasibility And Pilot Study: First-in-Human (FIH) Trials, Device Safety Assessment, Procedural Feasibility Studies, Prototype Testing

2) By Pivotal Study: Comparative Effectiveness Studies, Randomized Controlled Trials (RCTs), Non-Inferiority Trials, Superiority Trials

3) By FDA PMA (Pre-Market Approval) Application: Clinical Data Submission, Device Risk Analysis, Effectiveness Evidence Studies, Manufacturing Process Validation

4) By Post-Approval Study: Long-Term Safety Monitoring, Real-World Evidence Collection, Registry Studies, Comparative Outcome Studies

Which Market Trends Are Creating New Opportunities In The Medical Device Clinical Trials Industry?

Leading entities operating within the medical device clinical trials market are concentrating on developing AI-powered medical device software to refine clinical trial protocols and optimize resource distribution, thereby enhancing trial efficiency and reducing costs. AI-powered medical device software refers to applications used in healthcare that leverage artificial intelligence (AI) algorithms, particularly machine learning or deep learning, to support or automate various medical tasks. For instance, in January 2025, Risklick, a Switzerland-based pharmaceutical company, launched Protocol AI, an AI-driven software designed to accelerate and optimize clinical trials for medical devices. Protocol AI utilizes Natural Language Processing (NLP) and Machine Learning (ML) to analyze clinical data, publications, and regulatory documents, automatically drafting clinical trial protocols in minutes. This innovation significantly lowers the time and expense required for protocol development, a process that traditionally takes about six months, and has already demonstrated up to a 50% reduction in document development time for medicinal products.

Which Major Industry Participants Are Leading The Medical Device Clinical Trials Market Growth?

Major companies operating in the medical device clinical trials market are Abbott Laboratories, Siemens Healthineers, Stryker Corporation, Philips Healthcare, Baxter International, Roche Diagnostics, ICON, Intuitive Surgical, Edwards Lifesciences, Fortrea, Medidata, NAMSA, Veranex, TFS HealthScience, Avania, Parexel, Meditrial, Syneos Health, Qserve CRO, Clinius Ltd, Eclevar Medtech, 1med Sa, ISS AG

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/medical-device-clinical-trials-global-market-report

How Is Medical Device Clinical Trials Market Demand Varying Across Different Regions?

North America was the largest region in the medical device clinical trials market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medical device clinical trials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Medical Device Clinical Trials Market Report:

https://www.thebusinessresearchcompany.com/customise?id=24295&type=smp

Browse Through More Reports Similar to the Global Medical Device Clinical Trials Market 2025, By The Business Research Company

Medical Refrigerators Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/medical-refrigerators-global-market-report

Medical Plastics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/medical-plastics-global-market-report

Medical Adhesive Tapes Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/medical-adhesive-tapes-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Medical Device Clinical Trials Market Grown from 2024 to 2025?

In the past few years, the medical device clinical trials market has experienced robust growth. The market, which currently stands at $16.87 billion in 2024, is expected to see a rise to $18.12 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 7.4%. Factors contributing to this growth in the historic period include an increase in chronic diseases, rising demand for novel medical technologies, supportive regulations for clinical research, the growth of the aging population, improvements in healthcare infrastructure, and heightened investments from both the public and private sectors.

What Growth Rate Is Anticipated for the Medical Device Clinical Trials Market in the Coming Years?

The market size for medical device clinical trials is projected to experience considerable growth in the coming years. An increase to $23.91 billion is anticipated by 2029, with a compound annual growth rate (CAGR) of 7.2%. Whys for this growth during the forecast period are manifold: advancing demand for tailor-made medical devices, an upsurge in focusing on real-world evidence, an escalating application of AI in trial structuring and supervision, the broadening of decentralized and virtual trials, regulatory backing for expedited approvals, and rising investments in digital health progressions. Key trends during this forecast period consist of the acceptance of decentralized trials, the incorporation of AI and big data analytics, the employment of wearable monitoring devices, improved regulatory synchronization, and leaps forward in trial design and data analysis.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24295&type=smp

Who Are the Leading Companies in the Medical Device Clinical Trials Market?

Major companies operating in the medical device clinical trials market are Abbott Laboratories, Siemens Healthineers, Stryker Corporation, Philips Healthcare, Baxter International, Roche Diagnostics, ICON, Intuitive Surgical, Edwards Lifesciences, Fortrea, Medidata, NAMSA, Veranex, TFS HealthScience, Avania, Parexel, Meditrial, Syneos Health, Qserve CRO, Clinius Ltd, Eclevar Medtech, 1med Sa, ISS AG

What Are the Key Drivers of the Medical Device Clinical Trials Market?

The anticipated increase in chronic disease cases is predicted to stimulate the expansion of the medical device clinical trials market. Chronic illnesses are long-lasting health issues that evolve gradually and necessitate sustained medical intervention. These ailments are becoming more prevalent due to inactive lifestyles where individuals spend lengthy hours seated at desks or using electronic gadgets. This contributes to a reduction in calorie burn and deteriorates cardiovascular health, resulting in conditions like obesity, diabetes, and hypertension. Such escalating chronic illnesses amplify the demand for medical device clinical trials to formulate and authenticate ground-breaking devices for efficient diagnosis, treatment, and administration. For example, in June 2023, the Institute for Health Metrics and Evaluation, a public health research institute based in the United States, disclosed that over half a billion people worldwide had diabetes. This statistic is projected to more than double, hitting 1.3 billion individuals by 2050. Hence, the increasing frequency of chronic diseases is fueling the growth of the medical device clinical trials market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24295&type=smp

What Are the Key Market Segments in the Medical Device Clinical Trials Industry?

The medical device clinical trials market covered in this report is segmented –

1) By Study Type: Feasibility And Pilot Study, Pivotal Study, FDA Pre market Approval (PMA) Application, Post-Approval Study

2) By Indication: Cardiovascular Devices, Neurology Devices, Orthopedic Devices, Diagnostic Imaging, Anesthesia And Respiratory Devices, Other Indications

3) By Study Design: Interventional, Observational, Expanded Access

Subsegments:

1) By Feasibility And Pilot Study: First-in-Human (FIH) Trials, Device Safety Assessment, Procedural Feasibility Studies, Prototype Testing

2) By Pivotal Study: Comparative Effectiveness Studies, Randomized Controlled Trials (RCTs), Non-Inferiority Trials, Superiority Trials

3) By FDA PMA (Pre- market Approval) Application: Clinical Data Submission, Device Risk Analysis, Effectiveness Evidence Studies, Manufacturing Process Validation

4) By Post-Approval Study: Long-Term Safety Monitoring, Real-World Evidence Collection, Registry Studies, Comparative Outcome Studies

What Are the Latest Trends in the Medical Device Clinical Trials Market?

Leading businesses in the medical device clinical trials market are concentrating on creating AI-driven medical device software to improve clinical trial protocols and resource distribution to boost trial efficiency and lower expenses. AI-driven medical device software is healthcare software that utilizes AI algorithms, particularly machine learning or deep learning, to facilitate or automate medical tasks. For example, in January 2025, Risklick, a pharmaceutical firm based in Switzerland, introduced Protocol AI, an AI-powered software intended to expedite and enhance clinical trials for medical devices. Protocol AI uses Natural Language Processing (NLP) and Machine Learning (ML) to scrutinize clinical data, publications, and regulatory documents, and can draft clinical trial protocols in minutes. This advancement greatly lowers the time and expense associated with protocol development, which generally takes about six months. It has already shown a potential 50% reduction in the time required for developing documents for medicinal products.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/medical-device-clinical-trials-global-market-report

What Are the Key Regional Markets in the Medical Device Clinical Trials Industry?

North America was the largest region in the medical device clinical trials market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medical device clinical trials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/customise?id=24295&type=smp

This Report Delivers Insight On:

1. How big is the medical device clinical trials market, and how is it changing globally?

2. Who are the major companies in the medical device clinical trials market, and how are they performing?

3. What are the key opportunities and risks in the medical device clinical trials market right now?

4. Which products or customer segments are growing the most in the medical device clinical trials market?

5. What factors are helping or slowing down the growth of the medical device clinical trials market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model